- Pharma and Medtech outsourced services: value add services that support innovators in appraising, researching, developing and manufacturing new products. Benefiting from a structural outsourcing trend from large Innovators and a fundamental need for third party services from small Biotechs.
- Pharma products: specialised pharmaceutical products with limited exposure to public sector funding pressures. Particular focus on products currently or that have the potential to address the global marketing place.
- Medtech products: innovative and IP-rich Medtech products serving the Diagnostic sector or with the potential to expand their addressable market through internationalisation.